| pubmed-article:1483736 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1483736 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:1483736 | lifeskim:mentions | umls-concept:C1533685 | lld:lifeskim |
| pubmed-article:1483736 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:1483736 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
| pubmed-article:1483736 | lifeskim:mentions | umls-concept:C0013766 | lld:lifeskim |
| pubmed-article:1483736 | lifeskim:mentions | umls-concept:C0032616 | lld:lifeskim |
| pubmed-article:1483736 | lifeskim:mentions | umls-concept:C0042362 | lld:lifeskim |
| pubmed-article:1483736 | lifeskim:mentions | umls-concept:C0182324 | lld:lifeskim |
| pubmed-article:1483736 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:1483736 | pubmed:dateCreated | 1993-2-12 | lld:pubmed |
| pubmed-article:1483736 | pubmed:abstractText | This report describes the safety and efficacy of the procedure for percutaneous injection of medical-grade polyurethane elastomer (MPU) to form plugs in the vas deferens. The injection of 0.16-0.22 ml MPU in 53 men resulted in occlusion and azoospermia in 85% of the men after 12 months; 96% achieved azoospermia by 2 years. The success rate of the method and the rate of sperm suppression to azoospermia depended on the shapes of the plugs; this was determined by palpation after insertion. There were few complications and the results are discussed in terms of the reversibility potential of this method. | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:keyword | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1483736 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1483736 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1483736 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1483736 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:1483736 | pubmed:issn | 0105-6263 | lld:pubmed |
| pubmed-article:1483736 | pubmed:author | pubmed-author:ZWISS | lld:pubmed |
| pubmed-article:1483736 | pubmed:author | pubmed-author:ChenZ WZW | lld:pubmed |
| pubmed-article:1483736 | pubmed:author | pubmed-author:YinE JEJ | lld:pubmed |
| pubmed-article:1483736 | pubmed:author | pubmed-author:GoY SYS | lld:pubmed |
| pubmed-article:1483736 | pubmed:author | pubmed-author:LiangX WXW | lld:pubmed |
| pubmed-article:1483736 | pubmed:author | pubmed-author:Li-Hong | lld:pubmed |
| pubmed-article:1483736 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1483736 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:1483736 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1483736 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1483736 | pubmed:pagination | 468-72 | lld:pubmed |
| pubmed-article:1483736 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:1483736 | pubmed:otherAbstract | PIP: In China, physicians performed percutaneous injection of medical-grade polyurethane (MPU) in 53 men at the National Research Institute for Family Planning in Beijing and followed them for 2 years to evaluate the safety and efficacy of MPU vas occlusion. The injection of 1% procaine solution was used to kill residual spermatozoa in the distal reproductive tract. 1 year and within-subject fructose levels did not fluctuate greatly. 85% of the men reached azoospermia within 1 year after vas occlusion. 96% were azoospermic at 18 months. 2 men still had spermatozoa in the semen after 2 years (8-48 million ml-1). Both MPU plugs in most men (74%) had a regular shape. All of these men reached azoospermia by 18 months. 91% of the 11 men who had 1 regular and 1 irregular shaped MPU plug reached azoospermia by 18 months. This percentage fell to 67% for the 3 men whose MPU plugs were both irregular. The physicians had removed irregularly shaped MPU plugs in 5 men earlier and the elastomer filled the vas lumen and the surrounding vas surface. Recanalization did not occur in these 5 patients. 1 man with MPU vas occlusion developed a hematoma. 3 men experienced hemaspermia within 2 weeks after vas occlusion, but medication made it disappear within 4 weeks. Injection of 1% procaine solution may have damaged the seminal vesicles, resulting in the hemaspermia. Longterm complications did not occur. | lld:pubmed |
| pubmed-article:1483736 | pubmed:meshHeading | pubmed-meshheading:1483736-... | lld:pubmed |
| pubmed-article:1483736 | pubmed:meshHeading | pubmed-meshheading:1483736-... | lld:pubmed |
| pubmed-article:1483736 | pubmed:meshHeading | pubmed-meshheading:1483736-... | lld:pubmed |
| pubmed-article:1483736 | pubmed:meshHeading | pubmed-meshheading:1483736-... | lld:pubmed |
| pubmed-article:1483736 | pubmed:meshHeading | pubmed-meshheading:1483736-... | lld:pubmed |
| pubmed-article:1483736 | pubmed:meshHeading | pubmed-meshheading:1483736-... | lld:pubmed |
| pubmed-article:1483736 | pubmed:meshHeading | pubmed-meshheading:1483736-... | lld:pubmed |
| pubmed-article:1483736 | pubmed:meshHeading | pubmed-meshheading:1483736-... | lld:pubmed |
| pubmed-article:1483736 | pubmed:meshHeading | pubmed-meshheading:1483736-... | lld:pubmed |
| pubmed-article:1483736 | pubmed:meshHeading | pubmed-meshheading:1483736-... | lld:pubmed |
| pubmed-article:1483736 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1483736 | pubmed:articleTitle | Safety and efficacy of percutaneous injection of polyurethane elastomer (MPU) plugs for vas occlusion in man. | lld:pubmed |
| pubmed-article:1483736 | pubmed:affiliation | National Research Institute for Family Planning, Beijing, China. | lld:pubmed |
| pubmed-article:1483736 | pubmed:publicationType | Journal Article | lld:pubmed |
